Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-014328
Filing Date
2016-02-25
Accepted
2016-02-25 16:06:43
Documents
2
Period of Report
2016-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1603
2 EX-24 DOCUMENT attachment1.htm EX-24 5022
  Complete submission text file 0000899243-16-014328.txt   8033
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
McNinch David B. (Reporting) CIK: 0001666432 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 161455945